These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7926513)

  • 41. Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group.
    Petroni ML; Jazrawi RP; Pazzi P; Zuin M; Lanzini A; Fracchia M; Facchinetti D; Alvisi V; Ferraris R; Bland JM; Heaton KW; Podda M; Northfield TC
    Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):695-700. PubMed ID: 10912491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracorporeal shock-wave lithotripsy of gallbladder stones: an alternative for the selected few.
    Borch K; Jönsson KA; Lindström E; Carlsson P; Kullman E; Ihse I; Svanvik J
    Eur J Surg; 1996 May; 162(5):379-84. PubMed ID: 8781919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones.
    Tudyka J; Wechsler JG; Mason R; Maier C
    Am J Gastroenterol; 1994 Aug; 89(8):1206-10. PubMed ID: 8053436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
    Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
    Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combination therapy of gallbladder stones using extracorporeal shock waves and bile acids: results in relation to stone diameter and stone number].
    Stölzel U; Lenz K; Gregor M; Arntz R; Tung LC; Riecken EO
    Z Gastroenterol; 1992 Feb; 30(2):121-4. PubMed ID: 1553825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gallstone clearance: a randomized study of extracorporeal shock wave lithotripsy and chemical dissolution.
    Darzi A; Leahy A; O'Morain C; Tanner WA; Keane FB
    Br J Surg; 1990 Nov; 77(11):1265-7. PubMed ID: 2253006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gallstone recurrence after successful dissolution therapy.
    Tudyka J; Wechsler JG; Kratzer W; Maier C; Mason R; Kuhn K; Adler G
    Dig Dis Sci; 1996 Feb; 41(2):235-41. PubMed ID: 8601364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biliary lithotripsy: correlation between gallbladder contractility before treatment and the success of treatment.
    Donald JJ; Fache JS; Burhenne HJ
    AJR Am J Roentgenol; 1991 Aug; 157(2):287-90. PubMed ID: 1853808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
    Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
    Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biliary lithotripsy by extracorporeally generated shock waves.
    Sackmann M; Paumgartner G
    Recenti Prog Med; 1992; 83(7-8):400-6. PubMed ID: 1529154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term gallbladder stone recurrence and risk factors after successful lithotripsy.
    Carrilho-Ribeiro L; Pinto-Correia A; Velosa J; de Moura MC
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):209-15. PubMed ID: 10741937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does computed tomography improve patients selection for extracorporeal shock wave lithotripsy (ESWL) of radiolucent gallbladder stones?
    Franke F; Sackmann M; Holl J; Pauletzki J; Neubrand M; Paumgartner G; Sauerbruch T
    Z Gastroenterol; 1992 Mar; 30(3):180-2. PubMed ID: 1590013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects.
    Portincasa P; DiCiaula A; Palmieri V; Velardi A; Van Berge-Henegouwen GP; Palasciano G
    Ital J Gastroenterol; 1996; 28(2):111-3. PubMed ID: 8782006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bile acid therapy vs. placebo before and after extracorporeal shock wave lithotripsy of gallbladder stones].
    Ugeskr Laeger; 1998 Jun; 160(23):3408-12. PubMed ID: 9627510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracorporeal shock wave lithotripsy of gallstones with oral dissolution. Results in course of ten years in Czech Republic in correlation to indication criteria.
    Benes J; Chmel J; Blazek O; Marecek Z
    Sb Lek; 2001; 102(1):17-22. PubMed ID: 11830914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gallbladder emptying during high-dose cholecystokinin infusions. Effect in patients with gallstone disease and healthy controls.
    Pauletzki J; Cicala M; Spengler U; Sauerbruch T; Paumgartner G
    Scand J Gastroenterol; 1995 Feb; 30(2):128-32. PubMed ID: 7732334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones.
    Dhiman RK; Reddi R; Sharma A; Singh R; Kohli KK; Gupta S; Suri S; Chawla Y
    J Gastroenterol Hepatol; 2001 Jul; 16(7):816-20. PubMed ID: 11446892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Shock wave lithotripsy of gallbladder stones: the initial 54 patients treated in Rotterdam-Dijkzigt].
    den Toom R; Vergunst H; Nijs HG; Brakel K; Laméris JS; Terpstra OT
    Ned Tijdschr Geneeskd; 1990 Sep; 134(35):1692-7. PubMed ID: 2215718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones. The Dornier National Biliary Lithotripsy Study.
    Schoenfield LJ; Berci G; Carnovale RL; Casarella W; Caslowitz P; Chumley D; Davis RC; Gillenwater JY; Johnson AC; Jones RS
    N Engl J Med; 1990 Nov; 323(18):1239-45. PubMed ID: 2215608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.